Receptor binding affinity, receptor residence time, and pharmacokinetic properties all influence real-world outcomes
Whether youre managing diabetes or pursuing weight loss, patients typically start noticing significant improvements after a few weeks or months of treatment
Studies have shown that growth hormone plays a large role in converting adipose tissue into energy [8, 10]
If you have type 2 diabetes and take GLP-1 medications: Dont stop your medication without talking to your doctor first Switch to insulin before trying to conceive Get your blood sugar well-controlled before pregnancy Work with an endocrinologist for pregnancy management Visit our diabetes management services for specialized care
Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]